| 1 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Biocon Limited et al |
1:25-cv-00523 |
D.Del. |
|
|
|
|
| 2 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Biocon Limited et al |
1:25-cv-00523 |
D.Del. |
|
|
|
|
| 3 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Biocon Limited et al |
1:25-cv-00523 |
D.Del. |
|
|
|
|
| 4 |
Exelixis, Inc. v. Biocon Pharma Limited et al |
1:25-cv-00452 |
D.Del. |
|
|
|
|
| 5 |
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al |
1:23-cv-00334 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 6 |
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al |
1:23-cv-00334 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 7 |
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al |
1:23-cv-00334 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 8 |
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al |
1:23-cv-00334 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|